| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 11/03/2010 | EP2244692A2 Inhalation drug products, systems and uses |
| 11/03/2010 | EP2244591A1 A palatable nutritional composition comprising a nucleotide and/or a nucleoside and a taste masking agent |
| 11/03/2010 | EP2244577A1 Quinolizidinone m1 receptor positive allosteric modulators |
| 11/03/2010 | EP2244575A1 Angiotensin ii receptor antagonists |
| 11/03/2010 | EP2244574A1 Tricyclic compounds as modulators of tnf- synthesis and as pde4 inhibitors |
| 11/03/2010 | EP2244572A2 Use of ibogamine congeners for treating obesity |
| 11/03/2010 | EP2244571A1 Small molecule inhibitors of hiv proteases |
| 11/03/2010 | EP2136807B1 Pyrrolo (3, 2, 1-ij) quinoline-4-one derivatives for treating tuberculosis |
| 11/03/2010 | EP2125827B1 Azaspiro derivatives |
| 11/03/2010 | EP2121678B1 Novel chromen-2-one derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
| 11/03/2010 | EP2121677B1 Novel chromen-2-one derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
| 11/03/2010 | EP2066683B1 Derivatives of 5-thioxylopyranose and use of same for treatment |
| 11/03/2010 | EP2049544B1 Purinone derivatives as hm74a agonists |
| 11/03/2010 | EP2046331B1 Use of 3- (4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione for the treatment of mantle cell lymphomas |
| 11/03/2010 | EP2029572B1 Organic compounds |
| 11/03/2010 | EP2029556B1 Salts and crystal modifications thereof |
| 11/03/2010 | EP2010498B1 Synthesis of acylaminoalkenylene amides useful as substance p antagonists |
| 11/03/2010 | EP1998762B1 Solid dosage form containing a taste masked active agent |
| 11/03/2010 | EP1976525B1 Piperidine and piperazine derivatives |
| 11/03/2010 | EP1973541B1 Use of benzo-fused heterocycle sulfamide derivatives for lowering lipids and lowering blood glucose levels |
| 11/03/2010 | EP1970372B1 Salts of 9-oxoacridine-10-acetic acid with 1-alkylamno-1-desoxy-polyols |
| 11/03/2010 | EP1957088B1 Viscosupplementation with algal polysaccharides in the treatment of arthritis |
| 11/03/2010 | EP1954274B1 Substituted quinolones and methods of use |
| 11/03/2010 | EP1951725B1 N-sulfamoyl-n -benzopyranpiperidines as inhbitors of carbonic anhydrases |
| 11/03/2010 | EP1882474B1 Prophylactic/therapeutic agent for abnormalities of lipid metabolism |
| 11/03/2010 | EP1869036B1 Substituted 1,5-naphthyridine azolidinones as cdk inhibitors |
| 11/03/2010 | EP1865990B1 Method of treating type-2 diabetes |
| 11/03/2010 | EP1863477B1 3,4-substituted pyrrolidine derivatives for the treatment of hypertension |
| 11/03/2010 | EP1862183B1 Kit comprising drug and fat emulsion |
| 11/03/2010 | EP1858910B1 Novel betulinic acid derivatives a-ring-condensed to a heterocyclic group |
| 11/03/2010 | EP1855695B1 Solid pharmaceutical composition comprising telithromycin |
| 11/03/2010 | EP1846406B1 Maleimide derivatives, pharmaceutical compositions and methods for treatment of cancer |
| 11/03/2010 | EP1828178B1 Process for preparation of high-purity meloxicam and meloxicam potassium salt |
| 11/03/2010 | EP1805155B1 Thrombopoietin activity modulating compounds and methods |
| 11/03/2010 | EP1802313B1 Therapeutic agents trageting the ncca-atp channel and methods of use thereof |
| 11/03/2010 | EP1797053B1 Phenothiazinium compound for wound healing |
| 11/03/2010 | EP1781667B1 Benzothienopyridines for use as inhibitors of eg5 kinesin |
| 11/03/2010 | EP1781291B1 Opioids for the treatment of the restlessness of the lower limbs |
| 11/03/2010 | EP1781260B1 Extended release tablet formulation containing pramipexole or a pharmaceutically acceptable salt thereof, method for manufacturing the same and use thereof |
| 11/03/2010 | EP1765342B1 Pharmaceutical composition comprising amlodipine besilate and lisinopril dihydrate and process for the preparation thereof |
| 11/03/2010 | EP1745002B1 Novel compounds, their preparation and use |
| 11/03/2010 | EP1741792B1 Novel ligand of g-protein-conjugated receptor protein and use thereof |
| 11/03/2010 | EP1713798B1 C10 cyclopentyl ester substituted taxanes |
| 11/03/2010 | EP1703902B1 Memantine for the treatment of mild-to-moderate alzheimer's disease |
| 11/03/2010 | EP1702625B1 Medicine containing genetically modified antibody against chemokine receptor ccr4 |
| 11/03/2010 | EP1696825B1 Use of alginate matrices to control cell growth |
| 11/03/2010 | EP1660511B1 Novel tricyclic nucleosides or nucleotides as therapeutic agents |
| 11/03/2010 | EP1646622B1 Tacrine derivatives as inhibitors of acetylcholinesterase |
| 11/03/2010 | EP1556080B1 Furin inhibitors for use in the treatment of fibrosis and scarring |
| 11/03/2010 | EP1515966B1 Hydroxy pyranone derivative and preparation method thereof |
| 11/03/2010 | EP1499742B1 Nad(p)h oxidase inhibitors for increased glucose uptake and treatment of type ii diabetes |
| 11/03/2010 | EP1496838B1 Substituted amides |
| 11/03/2010 | EP1490080B1 medical use of anthocyanins extracted from black rice |
| 11/03/2010 | EP1485093B1 Di-aryl substituted tetrazole modulators of metabotropic glutamate receptor-5 |
| 11/03/2010 | EP1469834B1 Multi-stage oral drug controlled-release system |
| 11/03/2010 | EP1467715B1 Formulations for oral administration of active compounds |
| 11/03/2010 | EP1406615B1 Kinase inhibitors and the use thereof |
| 11/03/2010 | EP1404302B1 Pharmaceutical compositions comprising adsorbates of amorphous drug |
| 11/03/2010 | EP1296929B1 Modified forms of pharmacologically active agents and uses therefor |
| 11/03/2010 | EP1292292B1 Method for treating congestive heart failure |
| 11/03/2010 | EP1242437B1 Novel stromelysin inhibitors |
| 11/03/2010 | EP1220838B1 1-aziridino-1-hydroxyiminomethyl-derivatives, method for the production thereof and medicaments containing said compounds |
| 11/03/2010 | EP1137813B1 Method of drying a lactulose solution |
| 11/03/2010 | EP0961837B1 Chimeric antisense oligonucleotides |
| 11/03/2010 | EP0938320B9 Method enabling use of extracellular rna extracted from plasma or serum to detect, monitor or evaluate cancer |
| 11/03/2010 | EP0719273B1 Nucleotide analogs |
| 11/03/2010 | CN1997350B Tobacco alkaloid releasing chewing gum |
| 11/03/2010 | CN1980938B Mitotic kinesin inhibitors |
| 11/03/2010 | CN1958074B Injectable block copolymer hydrogel of temperature sensibility(epsi - caprolactone - glycolide)- polyethyleneglycol |
| 11/03/2010 | CN1951390B Pharmaceutical compositions comprising colloidal silicon dioxide |
| 11/03/2010 | CN1951375B Nicotine transdermal formulation and its production method |
| 11/03/2010 | CN1950370B Enantiomer-pure hexahydro- pyrrolocyclopenta- pyridine derivatives |
| 11/03/2010 | CN1919251B Traditional Chinese medicine composition for treating cardiac vascular disease |
| 11/03/2010 | CN1876004B A medicament for treating cerebrovascular disease |
| 11/03/2010 | CN1872137B Drop pills of total glycoside of Jiaogulan, and preparation method |
| 11/03/2010 | CN1872076B Drop pills of cucurbitacine, and preparation method |
| 11/03/2010 | CN1872075B Drop pills of hemsleyadin, and preparation method |
| 11/03/2010 | CN1872062B Fibrauretine, and preparation method |
| 11/03/2010 | CN1872059B Drop pills of matrine, and preparation method |
| 11/03/2010 | CN1872054B Drop pills of coumarin acetic acid, and preparation method |
| 11/03/2010 | CN1872053B Drop pills of daphnetin, and preparation method |
| 11/03/2010 | CN1872036B Drop pills of agrimophol, and preparation method |
| 11/03/2010 | CN1857593B Cough-treating preparation |
| 11/03/2010 | CN1850062B Fatty acid eye nano preparations for dry eye disease |
| 11/03/2010 | CN1837198B Tanshinone IIA derivatives and pharmaceutical application thereof |
| 11/03/2010 | CN1812812B Serum cholesterol lowering agnet or preventive or therapeutic agent for atherosclerosis |
| 11/03/2010 | CN1805744B New n-hydroxy-4-(3-phenyl-5-methyl-isoxazole-4-yl)-benzenesulfonamide solvates |
| 11/03/2010 | CN1738634B Extract of stephaniae sinica diels and methods of using the same |
| 11/03/2010 | CN1615295B Compounds for treatment of inflammation, diabetes and related disorders |
| 11/03/2010 | CN1393438B Taxane derivative and its preparing process and usage |
| 11/03/2010 | CN1310715B Polymorph of medicine |
| 11/03/2010 | CN101878305A Mcp-i binding nucleic acids and use thereof |
| 11/03/2010 | CN101878229A Immunoliposomes for treatment of cancer |
| 11/03/2010 | CN101878221A Novel glucocorticoid receptor agonists |
| 11/03/2010 | CN101878219A Imidazolothiadiazoles for use as protein kinase inhibitors |
| 11/03/2010 | CN101878217A Agent for prevention and/or treatment of skin diseases |
| 11/03/2010 | CN101878216A Pyrimidine derivatives as protein kinase inhibitors |
| 11/03/2010 | CN101878215A Polymorphs of a C-MET/HGFR inhibitor |
| 11/03/2010 | CN101878214A Benzomorphan compounds |
| 11/03/2010 | CN101878213A Alpha-fluoroalkyl tetrabenazine and dihydrotetrabenazine imaging agents and probes |